Researchers Uncover New Driver in High-Risk Neuroblastoma

High-risk neuroblastoma is an aggressive childhood cancer with poor treatment outcomes, and less than 50% of children survive for five years. Now, a new study by researchers in the Feng lab at Boston University School of Medicine, in collaboration with scientists in the Simon lab at the Perelman School of Medicine at the University of Pennsylvania, reveals that a metabolic enzyme promotes metastatic spread of neuroblastoma.